查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1364962

IVD 品质控制市场：按服务提供（产品、数据管理、服务）、按技术（生物化学、分子、免疫测定、血液学）、按应用（传染病、肿瘤学、心臟病学）、按最终用户- 2030 年之前的世界预测

IVD Quality Control Market by Offering (Product, Data Management, Service), Technology (Biochemistry, Molecular, Immunoassay, Hematology), Application (Infectious Diseases, Oncology, Cardiology), and End User - Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 267 Pages | 订单完成后即时交付

价格

IVD 品质管制市场：依产品（产品[血清、血液、尿液]、资料管理、服务）、依技术（生物化学、分子、免疫测定、血液学）、依应用（传染病、肿瘤学）、心臟病学） ，按最终用户 - 2030 年全球预测

IVD品质控制市场预计到2030年将达到21.9亿美元，2023年至2030年的复合年增长率为4.3%。

经过广泛的初级和二级研究，本报告对 IVD 品质控制市场进行了深入分析。 它还提供了有关 IVD 品质控制市场的关键驱动因素、市场限制、挑战和机会的见解。 IVD品质控制市场的成长是由于慢性病盛行率上升、老年人口不断增长、对第三方品质控制的需求不断增加、对内部和外部品质评估报告的需求以及临床品质控制的成长所推动的。实验室的数量以及对现场护理和快速诊断的需求不断增加。 然而，严格的技术要求和品质控制监管流程限制了该市场的成长。

对多项目和多分析物测试的需求不断增长是市场成长的机会。 然而，不断变化的监管环境和缺乏品质控制/品质保证材料是市场成长的主要挑战。

到 2023 年，品质控制产品领域预计将占据 IVD 品质控制市场的最大份额。 诊断产品的采用增加、对外部品质评估计划的需求（因为这些计划中使用了品质控制）、多分析物品质控制的开发、新产品的发布以及对独立控制的需求增加。它贡献了最大份额部分。

从技术角度来看，免疫分析/免疫化学领域预计将在 2023 年占据 IVD 品质控制市场的最大份额。 慢性病和传染病的日益普及、免疫测定/免疫化学测试的日益采用、这些测试的技术创新以及品质控制的同步发展正在为这一领域的最大份额做出贡献。

在这些应用中，预计2023年传染病领域将占据IVD品质控制市场的最大份额。 由于传染病的日益流行，可以采用广泛的品质控制来监控肝炎、逆转录病毒、性传播疾病和先天性疾病等传染病的体外诊断药物（IVD）检测的测量准确性。曾经。 根据世界卫生组织统计，2020年全球报告新增性传染感染病例3.76亿例，其中衣原体病例1.29亿例、淋病病例8200万例、梅毒病例710万例、滴虫病估计有1.56亿例。 诊断此类传染病的需要还需要对测试品质评估进行品质控制，这进一步支持了该细分市场的最大份额。

在最终用户中，医院和诊所预计将在 2023 年占据 IVD 品质控制市场的最大份额。 这一巨大的细分市场份额主要是由医院进行的大量诊断测试、医疗保健相关感染 (HAI) 患病率上升、医疗保健成本上升以及新兴市场医院和诊所数量不断增加推动的。

IVD 品质控制市场区域情境的详细分析提供了五个主要区域（北美、欧洲、亚太地区、拉丁美洲、中东和非洲）的详细定性和定量见解，并提供了国家覆盖范围。 预计到2023年，北美将占据IVD品质控制市场的最大份额，其次是欧洲、亚太地区、拉丁美洲、中东和非洲。 慢性病和传染病的高盛行率、疾病早期诊断意识的提高、先进诊断产品的采用增加、筹款活动增加以及诊断技术的新发展，再加上这是支持市场份额的因素。

调查范围：

IVD 品质控制市场中产品供应的评估

  • 品质控制产品
    • 品质控制产品（依产品类型）
  • 以血清/血浆为基础的对照
  • 基于全血
  • 基于尿液的控制
  • 其他控件
    • 依功能划分的品质管制产品
  • 独立控制
  • 特定于设备的控制
  • 品质评估服务
  • 资料管理解决方案

註释其他对照组包括基于唾液的对照、基于脑脊髓液的对照和蛋白质对照。

依技术评估 IVD 品质管制市场

  • 免疫测定/免疫化学
  • 生物化学/临床化学
  • 分子诊断
  • 血液学
  • 凝血/止血
  • 微生物学
  • 其他技术

註释其他技术包括组织化学、尿液分析、全血糖监测等。

按应用分类的 IVD 品质控制市场评估

  • 传染病
  • 肿瘤学
  • 心臟病学
  • 自体免疫疾病
  • 神经病学
  • 其他

Annotation 其他应用包括怀孕和不孕症检测、药物滥用检测、糖尿病、遗传疾病、微量元素检测等。

最终用户对 IVD 品质控制市场的评估

  • 医院/诊所
  • 诊断实验室
  • 学术机构与研究机构
  • 其他最终用户

注意其他最终使用者包括居家照护、疗养院、门诊照护中心、输血实验室等。

IVD品质控制市场的区域评估

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 中东/非洲

目录

第一章简介

第二章研究方法

第 3 章执行摘要

第 4 章市场洞察

  • 市场
  • 摘要
  • 影响市场成长的因素
    • 市场动态影响分析
    • 因素分析
  • 技术趋势
  • 监理分析
    • IVD 产品法规
      • 北美
        • 美国
        • 加拿大
      • 欧洲
      • 亚太地区
        • 中国
        • 日本
        • 印度
      • 拉丁美洲
      • 中东/非洲
    • 有关品质管制的规定
      • 北美
        • 美国
        • 加拿大
      • 欧洲
        • 德国
        • 法国
        • 英国
        • 义大利
        • 西班牙
        • 其他欧洲 (RoE)
      • 亚太地区
        • 中国
        • 日本
        • 印度
        • 其他亚太地区 (RoAPAC)
      • 拉丁美洲
      • 中东/非洲
  • 价格分析
  • 波特五力分析
  • 相关市场分析：体外诊断（IVD）市场

第五章体外诊断药物（IVD）品质管制市场：产品特定评估

  • 摘要
  • 品质控制产品
    • 品质控制产品（按类型）
      • 基于血清/血浆的控制
      • 基于全血
      • 基于尿液的控制
      • 其他控件
    • 依功能划分的品质管制产品
      • 独立控制
      • 特定于设备的控制
  • 品质评估服务
  • 资料管理解决方案

第六章 IVD 品质管制市场的技术评估

  • 摘要
  • 免疫测定/免疫化学
  • 生物化学/临床化学
  • 分子诊断
  • 血液学
  • 凝血/止血
  • 微生物学
  • 其他技术

第七章 IVD 品质控制的全球市场：按应用评估

  • 摘要
  • 传染病
  • 肿瘤学
  • 循环系统
  • 自体免疫疾病
  • 神经病学
  • 其他用途

第8章最终使用者对IVD品质管制市场的评估

  • 摘要
  • 医院/诊所
  • 诊断实验室
  • 学术机构/研究机构
  • 其他最终用户

第九章IVD品质管制市场区域评估

  • 摘要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 中东/非洲

第10章竞争分析

  • 简介
  • 主要成长策略
  • 竞争基准测试
  • 竞争对手仪表板
    • 行业领导者
    • 市场差异化因素
    • 领先企业
    • 新兴公司

第十一章公司简介

  • Siemens Healthineers AG
    • 公司简介
    • 财务概览
    • 产品组合
    • SWOT分析
  • Bio-Rad Laboratories, Inc.
    • 公司简介
    • 财务概览
    • 产品组合
    • 策略发展
    • SWOT分析
  • Danaher Corporation
    • 公司简介
    • 财务概览
    • 产品组合
    • SWOT分析
  • LGC Group
    • 公司简介
    • 财务概览
    • 产品组合
    • 策略发展
    • SWOT分析
  • Thermo Fisher Scientific Inc.
    • 公司简介
    • 财务概览
    • 产品组合
    • 策略发展
    • SWOT分析
  • Randox Laboratories Ltd.
    • 公司简介
    • 产品组合
    • 策略发展
    • SWOT分析
  • SERO AS
    • 公司简介
    • 产品组合
    • 策略发展
  • QuidelOrtho Corporation
    • 业务概览
    • 财务概览
    • 产品组合
    • 策略发展
  • Streck LLC
    • 公司简介
    • 产品组合
    • 策略发展
  • Microbiologics, Inc.
    • 公司简介
    • 产品组合
    • 策略发展
  • Bio-Techne Corporation
    • 公司简介
    • 财务概览
    • 产品组合
    • 策略发展

第12章附录

Product Code: MRHC - 104119

IVD Quality Control Market by Offering (Product [Serum, Blood, Urine-based], Data Management, Service), Technology (Biochemistry, Molecular, Immunoassay, Hematology), Application (Infectious Diseases, Oncology, Cardiology), and End User-Global Forecast to 2030

The IVD quality control market is expected to reach $2.19 billion by 2030, at a CAGR of 4.3% from 2023 to 2030.

After extensive primary and secondary research, the report provides an in-depth analysis of the IVD quality control market. The report also provides insights into the key drivers, restraints, challenges, and opportunities in the IVD quality control market. The growth of the IVD quality control market is driven by the rising prevalence of chronic diseases, coupled with the increasing geriatric population, growing demand for third-party quality controls, need for internal and external quality assessment reports, increasing number of clinical laboratories, growing demand for Point-of-Care (POC) and rapid diagnostics. However, stringent technical requirements and regulatory processes for quality controls restrain this market's growth.

The growing demand for multi-analyte and multi-instrument controls offers opportunities for market growth. However, the evolving regulatory landscape and lack of access to quality control/quality assurance materials are the major challenges to market growth.

Among the offering, in 2023, the quality control products segment is estimated to account for the largest share of the IVD quality control market. Increasing adoption of diagnostic products, demand for external quality assessment programs as these programs use quality controls in their programs, development of multi-analyte quality controls, new product launches, and increasing demand for independent controls contribute to the segments' largest share.

Among the technologies, in 2023, the immunoassay/immunochemistry segment is estimated to account for the largest share of the IVD quality control market. The growing prevalence of chronic and infectious diseases and the increased adoption of immunoassay/immunochemistry tests, technological innovations in these tests, and the simultaneous development of quality control contributed to the segment's largest share.

Among the application, in 2023, the infectious diseases segment is estimated to account for the largest share of the IVD quality control market. The increasing prevalence of infectious diseases has led to the availability of a broad range of quality controls that are designed to monitor the assay precision of IVD tests for infectious diseases such as hepatitis, retrovirus, sexually transmitted diseases, congenital diseases, and other infectious diseases. According to the WHO, in 2020, there were an estimated 376 million new cases of sexually transmitted infections (STIs) worldwide, with chlamydia accounting for 129 million, gonorrhea for 82 million, syphilis for 7.1 million, and trichomoniasis for 156 million of the reported cases. The need for diagnosis of such infectious diseases also required quality controls for the quality assessment of tests, which further supported the largest share of the segment.

Among the end users, in 2023, the hospitals & clinics segment is estimated to account for the largest share of the IVD quality control market. The large segment share is majorly attributed to the large volume of diagnostics tests carried out in the hospitals, the rising prevalence of healthcare-associated infections (HAIs), increasing healthcare expenditure, and the rising number of hospitals and clinics across emerging markets.

An in-depth analysis of the geographical scenario of the IVD quality control market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the IVD quality control market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The high prevalence of chronic and infectious diseases, increasing awareness regarding early disease diagnosis, growing adoption of advanced diagnostic products, and increasing funding activities, coupled with novel developments in diagnostic technologies, are the factors supporting the largest share of this market.

The key players operating in the IVD quality control market are Seimens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), LGC Group (U.K.), Thermo Fisher Scientific Inc. (U.S.), SERO AS (Norway), Randox Laboratories Ltd. (U.K.), QuidelOrtho Corporation (U.S.), Streck LLC (U.S.), Microbiologics, Inc. (U.S.), and Bio-Techne Corporation (U.S.)

Scope of the Report:

IVD Quality Control Market Assessment-by Offering

  • Quality Control Products
    • Quality Control Products, by Type
  • Serum/Plasma-based Controls
  • Whole Blood-based Controls
  • Urine-based Controls
  • Other Controls
    • Quality Control Products, by Function
  • Independent Controls
  • Instrument-Specific Controls
  • Quality Assessment Services
  • Data Management Solutions

Notes: Other controls include saliva-based controls, cerebrospinal fluid-based, and protein controls.

IVD Quality Control Market Assessment-by Technology

  • Immunoassay/Immunochemistry
  • Biochemistry/Clinical Chemistry
  • Molecular Diagnostics
  • Hematology
  • Coagulation/Hemostasis
  • Microbiology
  • Other Technologies

Notes: Other technologies include histochemistry, urinalysis, and whole-blood glucose monitoring

IVD Quality Control Market Assessment-by Application

  • Infectious Diseases
  • Oncology
  • Cardiology
  • Autoimmune Disorders
  • Neurology
  • Other Applications

Notes: Other applications include pregnancy and fertility testing, drug abuse testing, diabetes, genetic disorders, and trace elements testing

IVD Quality Control Market Assessment-by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic Institutes & Research Laboratories
  • Other End Users

Notes: Other end users include home care, nursing homes, ambulatory care centers, and transfusion laboratories.

IVD Quality Control Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Technology Trends
  • 4.4. Regulatory Analysis
    • 4.4.1. Regulations for IVD Products
      • 4.4.1.1. North America
        • 4.4.1.1.1. U.S.
        • 4.4.1.1.2. Canada
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia-Pacific
        • 4.4.1.3.1. China
        • 4.4.1.3.2. Japan
        • 4.4.1.3.3. India
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa
    • 4.4.2. Regulations for Quality Management
      • 4.4.2.1. North America
        • 4.4.2.1.1. U.S.
        • 4.4.2.1.2. Canada
      • 4.4.2.2. Europe
        • 4.4.2.2.1. Germany
        • 4.4.2.2.2. France
        • 4.4.2.2.3. U.K.
        • 4.4.2.2.4. Italy
        • 4.4.2.2.5. Spain
        • 4.4.2.2.6. Rest of Europe (RoE)
      • 4.4.2.3. Asia-Pacific
        • 4.4.2.3.1. China
        • 4.4.2.3.2. Japan
        • 4.4.2.3.3. India
        • 4.4.2.3.4. Rest of Asia-Pacific (RoAPAC)
      • 4.4.2.4. Latin America
      • 4.4.2.5. Middle East & Africa
  • 4.5. Pricing Analysis
  • 4.6. Porter's Five Forces Analysis
    • 4.6.1. Bargaining Power of Buyers
    • 4.6.2. Bargaining Power of Suppliers
    • 4.6.3. Threat of Substitutes
    • 4.6.4. Threat of New Entrants
    • 4.6.5. Degree of Competition
  • 4.7. Associated Market Analysis: In Vitro Diagnostics (IVD) Market

5. IVD Quality Control Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Quality Control Products
    • 5.2.1. Quality Control Products, by Type
      • 5.2.1.1. Serum/Plasma-based Controls
      • 5.2.1.2. Whole Blood-based Controls
      • 5.2.1.3. Urine-based Controls
      • 5.2.1.4. Other Controls
    • 5.2.2. Quality Control Products, by Function
      • 5.2.2.1. Independent Controls
      • 5.2.2.2. Instrument-specific Controls
  • 5.3. Quality Assessment Services
  • 5.4. Data Management Solutions

6. IVD Quality Control Market Assessment-by Technology

  • 6.1. Overview
  • 6.2. Immunoassay/Immunochemistry
  • 6.3. Biochemistry/Clinical Chemistry
  • 6.4. Molecular Diagnostics
  • 6.5. Hematology
  • 6.6. Coagulation/Hemostasis
  • 6.7. Microbiology
  • 6.8. Other Technologies

7. Global IVD Quality Control Market Assessment-by Application

  • 7.1. Overview
  • 7.2. Infectious Diseases
  • 7.3. Oncology
  • 7.4. Cardiology
  • 7.5. Autoimmune Disorders
  • 7.6. Neurology
  • 7.7. Other Applications

8. IVD Quality Control Market Assessment-by End User

  • 8.1. Overview
  • 8.2. Hospitals & Clinics
  • 8.3. Diagnostic Laboratories
  • 8.4. Academic Institutes & Research Laboratories
  • 8.5. Other End Users

9. IVD Quality Control Market Assessment-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies

11. Company Profiles

  • 11.1. Siemens Healthineers AG
    • 11.1.1. Company Overview
    • 11.1.2. Financial Overview
    • 11.1.3. Product Portfolio
    • 11.1.4. SWOT Analysis
  • 11.2. Bio-Rad Laboratories, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Overview
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Developments
    • 11.2.5. SWOT Analysis
  • 11.3. Danaher Corporation
    • 11.3.1. Company Overview
    • 11.3.2. Financial Overview
    • 11.3.3. Product Portfolio
    • 11.3.4. SWOT Analysis
  • 11.4. LGC Group
    • 11.4.1. Company Overview
    • 11.4.2. Financial Overview
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Developments
    • 11.4.5. SWOT Analysis
  • 11.5. Thermo Fisher Scientific Inc.
    • 11.5.1. Business Overview
    • 11.5.2. Financial Overview
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Developments
    • 11.5.5. SWOT Analysis
  • 11.6. Randox Laboratories Ltd.
    • 11.6.1. Company Overview
    • 11.6.2. Product Portfolio
    • 11.6.3. Strategic Developments
    • 11.6.4. SWOT Analysis
  • 11.7. SERO AS
    • 11.7.1. Company Overview
    • 11.7.2. Product Portfolio
    • 11.7.3. Strategic Developments
  • 11.8. QuidelOrtho Corporation
    • 11.8.1. Business Overview
    • 11.8.2. Financial Overview
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Developments
  • 11.9. Streck LLC
    • 11.9.1. Company Overview
    • 11.9.2. Product Portfolio
    • 11.9.3. Strategic Developments
  • 11.10. Microbiologics, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Product Portfolio
    • 11.10.3. Strategic Developments
  • 11.11. Bio-Techne Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Financial Overview
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Developments

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports
  • Table 1 A Comparison Between the Characteristics of PBRTQC and Statistical IQC
  • Table 2 Regulatory Authorities Governing IVD Quality Controls, by Country/Region
  • Table 3 IVD Quality Control Product Pricing
  • Table 4 Global IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 5 Global Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 6 Global Quality Control Products Market, by Country/Region, 2021-2030 (USD Million)
  • Table 7 Global Serum/Plasma-Based Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 8 Global Whole Blood-Based Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 9 Global Urine-Based Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 10 Global Other Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 11 Global Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 12 Global Independent Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 13 Global Instrument-Specific Controls Market, by Country/Region, 2021-2030 (USD Million)
  • Table 14 Global Quality Assessment Services Market, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global Data Management Solutions Market, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Global IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 17 Global IVD Quality Control Market for Immunoassay/Immunochemistry, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global IVD Quality Control Market for Biochemistry/Clinical Chemistry, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Global IVD Quality Control Market for Molecular Diagnostics, by Country/Region, 2021-2030 (USD Million)
  • Table 20 Global IVD Quality Control Market for Hematology, by Country/Region, 2021-2030 (USD Million)
  • Table 21 Global IVD Quality Control Market for Coagulation/Hemostasis, by Country/Region, 2021-2030 (USD Million)
  • Table 22 Global IVD Quality Control Market for Microbiology, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global IVD Quality Control Market for Other Technologies, by Country/Region, 2021-2030 (USD Million)
  • Table 24 Global IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 25 Global IVD Quality Control Market for Infectious Diseases, by Country/Region, 2021-2030 (USD Million)
  • Table 26 Increase in the Number of New Cancer Cases Globally (2020-2040)
  • Table 27 Global IVD Quality Control Market for Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 28 Global IVD Quality Control Market for Cardiology, by Country/Region, 2021-2030 (USD Million)
  • Table 29 Global IVD Quality Control Market for Autoimmune Disorders, by Country/Region, 2021-2030 (USD Million)
  • Table 30 Global IVD Quality Control Market for Neurology, by Country/Region, 2021-2030 (USD Million)
  • Table 31 Global IVD Quality Control Market for Other Applications, by Country/Region, 2021-2030 (USD Million)
  • Table 32 Global IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 33 Global IVD Quality Control Market for Hospitals & Clinics, by Country/Region, 2021-2030 (USD Million)
  • Table 34 Global IVD Quality Control Market for Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 35 Global IVD Quality Control Market for Academic Institutes & Research Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 36 Global IVD Quality Control Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
  • Table 37 Global IVD Quality Control Market, by Country/Region, 2021-2030 (USD Million)
  • Table 38 North America: Estimated Cancer Cases, 2020-2030
  • Table 39 North America: IVD Quality Control Market, by Country, 2021-2030 (USD Million)
  • Table 40 North America: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 41 North America: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 42 North America: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 43 North America: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 44 North America: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 45 North America: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 46 U.S.: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 47 U.S.: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 48 U.S.: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 49 U.S.: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 50 U.S.: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 51 U.S.: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 52 Canada: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 53 Canada: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 54 Canada: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 55 Canada: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 56 Canada: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 57 Canada: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 58 Europe: IVD Quality Control Market, by Country/Region, 2021-2030 (USD Million)
  • Table 59 Europe: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 60 Europe: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 61 Europe: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 62 Europe: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 63 Europe: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 64 Europe: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 65 Germany: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 66 Germany: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 67 Germany: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 68 Germany: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 69 Germany: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 70 Germany: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 71 France: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 72 France: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 73 France: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 74 France: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 75 France: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 76 France: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 77 U.K.: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 78 U.K.: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 79 U.K.: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 80 U.K.: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 81 U.K.: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 82 U.K.: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 83 Italy: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 84 Italy: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 85 Italy: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 86 Italy: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 87 Italy: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 88 Italy: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 89 Spain: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 90 Spain: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 91 Spain: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 92 Spain: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 93 Spain: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 94 Spain: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 95 Rest of Europe: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 96 Rest of Europe: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 97 Rest of Europe: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 98 Rest of Europe: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 99 Rest of Europe: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 100 Rest of Europe: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 101 Asia-Pacific: IVD Quality Control Market, by Country/Region, 2021-2030 (USD Million)
  • Table 102 Asia-Pacific: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 103 Asia-Pacific: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 104 Asia-Pacific: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 105 Asia-Pacific: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 106 Asia-Pacific: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 107 Asia-Pacific: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 108 China: Mass Testing Drives to Control The Spread of Covid-19 Infections
  • Table 109 China: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 110 China: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 111 China: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 112 China: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 113 China: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 114 China: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 115 Japan: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 116 Japan: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 117 Japan: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 118 Japan: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 119 Japan: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 120 Japan: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 121 India: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 122 India: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 123 India: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 124 India: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 125 India: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 126 India: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 127 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country (2020-2030)
  • Table 128 Rest of Asia-Pacific: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 129 Rest of Asia-Pacific: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 130 Rest of Asia-Pacific: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 131 Rest of Asia-Pacific: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 132 Rest of Asia-Pacific: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 133 Rest of Asia-Pacific: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 134 Latin America: IVD Quality Control Market, by Country/Region, 2021-2030 (USD Million)
  • Table 135 Latin America: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 136 Latin America: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 137 Latin America: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 138 Latin America: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 139 Latin America: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 140 Latin America: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 141 Brazil: Testing Initiatives for COVID-19
  • Table 142 Brazil: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 143 Brazil: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 144 Brazil: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 145 Brazil: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 146 Brazil: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 147 Brazil: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 148 Mexico: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 149 Mexico: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 150 Mexico: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 151 Mexico: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 152 Mexico: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 153 Mexico: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 154 Rest of Latin America: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 155 Rest of Latin America: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 156 Rest of Latin America: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 157 Rest of Latin America: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 158 Rest of Latin America: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 159 Rest of Latin America: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 160 Middle East & Africa: IVD Quality Control Market, by Offering, 2021-2030 (USD Million)
  • Table 161 Middle East & Africa: Quality Control Products Market, by Type, 2021-2030 (USD Million)
  • Table 162 Middle East & Africa: Quality Control Products Market, by Function, 2021-2030 (USD Million)
  • Table 163 Middle East & Africa: IVD Quality Control Market, by Technology, 2021-2030 (USD Million)
  • Table 164 Middle East & Africa: IVD Quality Control Market, by Application, 2021-2030 (USD Million)
  • Table 165 Middle East & Africa: IVD Quality Control Market, by End User, 2021-2030 (USD Million)
  • Table 166 Recent Developments, by Company, 2020-2023